World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
HALOHalozyme Therapeutics | $5.07bn | 18.88 | n/a |
MDGLMadrigal Pharmaceuticals | $4.89bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $4.74bn | n/a | n/a |
6990Sichuan Kelun-Biotech Biopharmaceutical Co | HK$35.95bn | n/a | n/a |
KRYSKrystal Biotech | $4.59bn | n/a | n/a |
NUVLNuvalent | $4.54bn | n/a | n/a |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
BIOCONBiocon | IN₹365.26bn | 31.12 | 0.49% |
ALPNAlpine Immune Sciences | $4.24bn | n/a | n/a |
IMVTImmunovant | $4.19bn | n/a | n/a |
MRTXMirati Therapeutics | $4.12bn | n/a | n/a |
ALKSAlkermes | $4.07bn | 6.83 | n/a |
ALKSVAlkermes | $4.05bn | 18.02 | n/a |
950160Kolon TissueGene | KR₩6tn | n/a | n/a |
ALVOAlvotech SA | $3.84bn | n/a | n/a |
RYZBRayzebio | $3.81bn | n/a | n/a |
IOVAIovance Biotherapeutics | $3.80bn | n/a | n/a |
INSMInsmed | $3.80bn | n/a | n/a |
CBAYCymaBay Therapeutics | $3.73bn | n/a | n/a |
CRNXCrinetics Pharmaceuticals | $3.72bn | n/a | n/a |